In vitro produced human antibodies in the treatment of superficial bladder cancer.
Corrado
F
F
First Division of Urology and Experimental Urology Service, M. Malpighi Hospital, Bologna, Italy.
Pizza
G
G
Casanova
S
S
De Vinci
C
C
Fini
M
M
Severini
G
G
Menniti
D
D
Corrado
G
G
D000368:Aged; D000369:Aged, 80 and over; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000943:Antigens, Differentiation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control / Q000628:therapy* / Q000648:ultrastructure; D003165:Complement System Proteins / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008854:Microscopy, Electron; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control / Q000628:therapy* / Q000648:ultrastructure
D000912:Antibodies, Neoplasm; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D003165:Complement System Proteins